Cryoport vs Pacific Biosciences Of California
Cryoport and Pacific Biosciences Of California are similar in size: $176m and $160m of revenue in their latest fiscal years. Cryoport grew faster (12.4% against 3.9%). Cryoport kept more of each dollar of sales as profit: a net margin of 44.4% against -341.5%. Cryoport carries less debt relative to equity (37.1% against 12065.5%).
| Latest fiscal year | CryoportCYRX, 2025 | Pacific Biosciences Of CaliforniaPACB, 2025 |
|---|---|---|
| Revenue | $176m | $160m |
| Revenue growth | 12.4% | 3.9% |
| Net income | $78.3m | −$546m |
| Operating margin | -20.9% | -346.2% |
| Net margin | 44.4% | -341.5% |
| Return on equity | 17.3% | — |
| Free cash flow | −$25.0m | −$114m |
| Cash | $250m | $63.7m |
| Total debt | $186m | $645m |
| Debt to equity | 37.1% | 12065.5% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $10.0m | — |
| Employees | 738 | 485 |
| Market value | $844m | $763m |
| Price vs our value range | — | — |
| Moat score | 19 (Weak) | 13 (Weak) |
| Insider trades, 12 months | 0 buys, 14 sales | 0 buys, 12 sales |